Events
Minimising uncertainty for biopharmaceutical payers and manufacturers is a key factor in maximising pricing and market access of orphan drugs.
Read MoreGPI will be attending World Orphan Drug Congress, held in Barcelona Spain on 14-17 November 2022.
Read MoreGPI will be attending the EPP Life Sciences Forum, held in Zurich, Switzerland on 18-20 October 2022.
Read MoreGPI will be attending four in-person conferences in October & November, talking to clients and showcasing our latest initiatives, products updates and presenting research. Our conference attendance includes: Reuters: Pharma, WODC, EPP and ISPOR, where will be showcasing four research posters.
Read MoreGPI will be presenting four research posters at ISPOR,held at the Austria Center, Vienna, Austria on 6-9 November 2022.
Read MoreCell and gene therapies (CGTs) offer potential curative and restorative treatments for previously untreatable diseases. This comes at an extremely high cost with some CGTs exceeding one million Euros.
Read MoreThe launch of new medicines is a complex process that requires careful consideration of pricing and reimbursement strategies. This webinar will provide an overview of the mechanisms of pricing and reimbursement that are essential to ensure the successful launch and uptake of new medicines.
Read MoreWe will talk about the importance of automating treatment data, as part of the Model N State Price Transparency webinar series.
Read MoreGPI will be presenting two research abstracts at the HTAi Annual Meeting, one as a poster presentation, and one as an oral presentation – 29 June 2022.
Read MoreGPI will be visiting the World EPA Congress in Amsterdam on 22-24 March.
Read More